Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aligos Therapeutics (ALGS) Treasury Shares (2021 - 2025)

Aligos Therapeutics (ALGS) has disclosed Treasury Shares for 5 consecutive years, with $76786.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares rose 1523.73% year-over-year to $76786.0, compared with a TTM value of $76786.0 through Dec 2025, up 1523.73%, and an annual FY2025 reading of $76786.0, up 1523.73% over the prior year.
  • Treasury Shares was $76786.0 for Q4 2025 at Aligos Therapeutics, roughly flat from $76861.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $303711.0 in Q1 2021 and bottomed at $3717.0 in Q2 2022.
  • Average Treasury Shares over 5 years is $90332.0, with a median of $76823.5 recorded in 2025.
  • The sharpest move saw Treasury Shares plummeted 98.35% in 2022, then surged 1635.4% in 2025.
  • Year by year, Treasury Shares stood at $89054.0 in 2021, then tumbled by 95.83% to $3717.0 in 2022, then skyrocketed by 44.26% to $5362.0 in 2023, then fell by 11.81% to $4729.0 in 2024, then skyrocketed by 1523.73% to $76786.0 in 2025.
  • Business Quant data shows Treasury Shares for ALGS at $76786.0 in Q4 2025, $76861.0 in Q3 2025, and $17264.0 in Q2 2025.